Table of Content

Table of Contents

1 Product Introduction and Overview
1.1 Product Definition
1.2 Product Specification
1.3 Global Market Overview
1.3.1 Global Human Microbiome Therapeutic Drugs Market Status and Forecast (2016-2027)
1.3.2 Global Human Microbiome Therapeutic Drugs Sales Value CAGR by Region
1.4 Market Drivers, Inhibitors
1.4.1 Market Drivers
1.4.2 Market Inhibitors
1.4.3 COVID-19 Impact Analysis
2 Global Human Microbiome Therapeutic Drugs Supply by Company
2.1 Global Human Microbiome Therapeutic Drugs Sales Value by Company
2.2 Human Microbiome Therapeutic Drugs Sales Area of Main Manufacturers
2.3 Trend of Concentration Rate
3 Global and Regional Human Microbiome Therapeutic Drugs Market Status by Type
3.1 Human Microbiome Therapeutic Drugs Type Introduction
3.1.1 FMT
3.1.2 Microbiome Drugs
3.1.3 Others
3.2 Global Human Microbiome Therapeutic Drugs Market by Type
3.3 North America: by Type
3.4 Europe: by Type
3.5 Asia Pacific: by Type
3.6 Central & South America: by Type
3.7 Middle East & Africa: by Type
4 Global and Regional Human Microbiome Therapeutic Drugs Market Status by Application
4.1 Human Microbiome Therapeutic Drugs Segment by Application
4.1.1 Stomach
4.1.2 Oral
4.1.3 Respiratory Tract
4.1.4 Others
4.2 Global Human Microbiome Therapeutic Drugs Market by Application
4.3 North America: by Application
4.4 Europe: by Application
4.5 Asia Pacific: by Application
4.6 Central & South America: by Application
4.7 Middle East & Africa: by Application
5 Global Human Microbiome Therapeutic Drugs Market Status by Region
5.1 Global Human Microbiome Therapeutic Drugs Market by Region
5.2 North America Human Microbiome Therapeutic Drugs Market Status
5.3 Europe Human Microbiome Therapeutic Drugs Market Status
5.4 Asia Pacific Human Microbiome Therapeutic Drugs Market Status
5.5 Central & South America Human Microbiome Therapeutic Drugs Market Status
5.6 Middle East & Africa Human Microbiome Therapeutic Drugs Market Status
6 North America Human Microbiome Therapeutic Drugs Market Status
6.1 North America Human Microbiome Therapeutic Drugs Market by Country
6.2 United States
6.3 Canada
6.4 Mexico
7 Europe Human Microbiome Therapeutic Drugs Market Status
7.1 Europe Human Microbiome Therapeutic Drugs Market by Country
7.2 Germany
7.3 France
7.4 UK
7.5 Italy
7.6 Russia
7.7 Spain
8 Asia Pacific Human Microbiome Therapeutic Drugs Market Status
8.1 Asia Pacific Human Microbiome Therapeutic Drugs Market by Country
8.2 China
8.3 Japan
8.4 Korea
8.5 Southeast Asia
8.6 India
8.7 Australasia
9 Central & South America Human Microbiome Therapeutic Drugs Market Status
9.1 Central & South America Human Microbiome Therapeutic Drugs Market by Country
9.2 Brazil
9.3 Argentina
9.4 Colombia
10 Middle East & Africa Human Microbiome Therapeutic Drugs Market Status
10.1 Middle East & Africa Human Microbiome Therapeutic Drugs Market by Country
10.2 Iran
10.3 Israel
10.4 Turkey
10.5 South Africa
10.8 Saudi Arabia
11 Major Downstream Customers Analysis
11.1 Customer One Analysis
11.2 Customer Two Analysis
11.3 Customer Three Analysis
11.4 Customer Four Analysis
12 Global Human Microbiome Therapeutic Drugs Market Forecast by Type and by Application
12.1 Global Human Microbiome Therapeutic Drugs Sales Value Forecast (2022-2027)
12.2 Global Human Microbiome Therapeutic Drugs Forecast by Type
12.3 Global Human Microbiome Therapeutic Drugs Forecast by Application
13 Global Human Microbiome Therapeutic Drugs Market Forecast by Region/Country
13.1 Global Human Microbiome Therapeutic Drugs Market Forecast by Region (2022-2027)
13.2 North America Market Forecast
13.3 Europe Market Forecast
13.4 Asia Pacific Market Forecast
13.5 Central & South America Market Forecast
13.6 Middle East & Africa Market Forecast
14 Key Participants Company Information
14.1 Vedanta Biosciences
14.1.1 Company Information
14.1.2 Human Microbiome Therapeutic Drugs Product Introduction
14.1.3 Vedanta Biosciences Human Microbiome Therapeutic Drugs Sales Value, Gross Margin and Global Share (2019-2021)
14.1.4 SWOT Analysis
14.2 Takeda
14.2.1 Company Information
14.2.2 Human Microbiome Therapeutic Drugs Product Introduction
14.2.3 Takeda Human Microbiome Therapeutic Drugs Sales Value, Gross Margin and Global Share (2019-2021)
14.2.4 SWOT Analysis
14.3 Seres Therapeutics
14.3.1 Company Information
14.3.2 Human Microbiome Therapeutic Drugs Product Introduction
14.3.3 Seres Therapeutics Human Microbiome Therapeutic Drugs Sales Value, Gross Margin and Global Share (2019-2021)
14.3.4 SWOT Analysis
14.4 Rebiotix
14.4.1 Company Information
14.4.2 Human Microbiome Therapeutic Drugs Product Introduction
14.4.3 Rebiotix Human Microbiome Therapeutic Drugs Sales Value, Gross Margin and Global Share (2019-2021)
14.4.4 SWOT Analysis
14.5 Johnson and Johnson
14.5.1 Company Information
14.5.2 Human Microbiome Therapeutic Drugs Product Introduction
14.5.3 Johnson and Johnson Human Microbiome Therapeutic Drugs Sales Value, Gross Margin and Global Share (2019-2021)
14.5.4 SWOT Analysis
14.6 ENTEROME Bioscience
14.6.1 Company Information
14.6.2 Human Microbiome Therapeutic Drugs Product Introduction
14.6.3 ENTEROME Bioscience Human Microbiome Therapeutic Drugs Sales Value, Gross Margin and Global Share (2019-2021)
14.6.4 SWOT Analysis
14.7 Bristol-Myers Squibb
14.7.1 Company Information
14.7.2 Human Microbiome Therapeutic Drugs Product Introduction
14.7.3 Bristol-Myers Squibb Human Microbiome Therapeutic Drugs Sales Value, Gross Margin and Global Share (2019-2021)
14.7.4 SWOT Analysis
...
15 Conclusion
16 Methodology

List of Figure

List of Tables

Table Global Human Microbiome Therapeutic Drugs Sales Value (Million USD) and CAGR by Region (2016-2027)
Table Global Human Microbiome Therapeutic Drugs Sales Value (Million USD) by Company (2019-2021)
Table Global Human Microbiome Therapeutic Drugs Sales Value Market Share by Company (2019-2021)
Table Main Manufacturers Human Microbiome Therapeutic Drugs Sales Area
Table Human Microbiome Therapeutic Drugs Market Concentration (Top 3, Top 5) (2019-2021)
Table Global Human Microbiome Therapeutic Drugs Sales Value (Million USD) by Type (2016-2021)
Table Global Human Microbiome Therapeutic Drugs Sals Value Market Share by Type (2016-2021)
Table North America Human Microbiome Therapeutic Drugs Sales Value (Million USD) by Type (2016-2021)
Table North America Human Microbiome Therapeutic Drugs Sales Value Market Share by Type (2016-2021)
Table Europe Human Microbiome Therapeutic Drugs Sales Value (Million USD) by Type (2016-2021)
Table Europe Human Microbiome Therapeutic Drugs Sales Value Market Share by Type (2016-2021)
Table Asia Pacific Human Microbiome Therapeutic Drugs Sales Value (Million USD) by Type (2016-2021)
Table Asia Pacific Human Microbiome Therapeutic Drugs Sales Value Market Share by Type (2016-2021)
Table Central & South America Human Microbiome Therapeutic Drugs Sales Value (Million USD) by Type (2016-2021)
Table Central & South America Pacific Human Microbiome Therapeutic Drugs Sales Value Market Share by Type (2016-2021)
Table Middle East & Africa Human Microbiome Therapeutic Drugs Sales Value (Million USD) by Type (2016-2021)
Table Middle East & Africa Human Microbiome Therapeutic Drugs Sales Value Market Share by Type (2016-2021)
Table Global Human Microbiome Therapeutic Drugs Sales Value (Million USD) by Application (2016-2021)
Table Global Human Microbiome Therapeutic Drugs Value Market Share by Application (2016-2021)
Table North America Human Microbiome Therapeutic Drugs Sales Value (Million USD) by Application (2016-2021)
Table North America Human Microbiome Therapeutic Drugs Sales Value Market Share by Application (2016-2021)
Table Europe Human Microbiome Therapeutic Drugs Sales Value (Million USD) by Application (2016-2021)
Table Europe Human Microbiome Therapeutic Drugs Sales Value Market Share by Application (2016-2021)
Table Asia Pacific Human Microbiome Therapeutic Drugs Sales Value (Million USD) by Application (2016-2021)
Table Asia Pacific Human Microbiome Therapeutic Drugs Sales Value Market Share by Application (2016-2021)
Table Central & South America Human Microbiome Therapeutic Drugs Sales Value (Million USD) by Application (2016-2021)
Table Central & South America Pacific Human Microbiome Therapeutic Drugs Sales Value Market Share by Application (2016-2021)
Table Middle East & Africa Human Microbiome Therapeutic Drugs Sales Value (Million USD) by Application (2016-2021)
Table Middle East & Africa Human Microbiome Therapeutic Drugs Sales Value Market Share by Application (2016-2021)
Table Global Human Microbiome Therapeutic Drugs Sales Value (Million USD) by Region (2016-2021)
Table Global Human Microbiome Therapeutic Drugs Value Market Share by Region (2016-2021)
Table North America Human Microbiome Therapeutic Drugs Sales Value (Million USD) by Country (2016-2021)
Table North America Human Microbiome Therapeutic Drugs Value Market Share by Country (2016-2021)
Table Europe Human Microbiome Therapeutic Drugs Sales Value (Million USD) by Country (2016-2021)
Table Europe Human Microbiome Therapeutic Drugs Value Market Share by Country (2016-2021)
Table Asia Pacific Human Microbiome Therapeutic Drugs Sales Value (Million USD) by Country (2016-2021)
Table Asia Pacific Human Microbiome Therapeutic Drugs Value Market Share by Country (2016-2021)
Table Central & South America Human Microbiome Therapeutic Drugs Sales Value (Million USD) by Country (2016-2021)
Table Central & South America Human Microbiome Therapeutic Drugs Value Market Share by Country (2016-2021)
Table Middle East & Africa Human Microbiome Therapeutic Drugs Sales Value (Million USD) by Country (2016-2021)
Table Middle East & Africa Human Microbiome Therapeutic Drugs Value Market Share by Country (2016-2021)
Table Global Human Microbiome Therapeutic Drugs Value (Million USD) Forecast by Type (2022-2027)
Table Global Human Microbiome Therapeutic Drugs Value Market Share Forecast by Type (2022-2027)
Table Global Human Microbiome Therapeutic Drugs Value (Million USD) Forecast by Application (2022-2027)
Table Global Human Microbiome Therapeutic Drugs Value Market Share Forecast by Application (2022-2027)
Table Global Human Microbiome Therapeutic Drugs Value (Million USD) Forecast by Region (2022-2027)
Table Global Human Microbiome Therapeutic Drugs Value Market Share Forecast by Region (2022-2027)
Table Vedanta Biosciences Company Information
Table Vedanta Biosciences Product Introduction
Table Vedanta Biosciences Human Microbiome Therapeutic Drugs Sales Value, Gross Margin and Global Share (2019-2021)
Table Takeda Company Information
Table Takeda Product Introduction
Table Takeda Human Microbiome Therapeutic Drugs Sales Value, Gross Margin and Global Share (2019-2021)
Table Seres Therapeutics Company Information
Table Seres Therapeutics Product Introduction
Table Seres Therapeutics Human Microbiome Therapeutic Drugs Sales Value, Gross Margin and Global Share (2019-2021)
Table Rebiotix Company Information
Table Rebiotix Product Introduction
Table Rebiotix Human Microbiome Therapeutic Drugs Sales Value, Gross Margin and Global Share (2019-2021)
Table Johnson and Johnson Company Information
Table Johnson and Johnson Product Introduction
Table Johnson and Johnson Human Microbiome Therapeutic Drugs Sales Value, Gross Margin and Global Share (2019-2021)
Table ENTEROME Bioscience Company Information
Table ENTEROME Bioscience Product Introduction
Table ENTEROME Bioscience Human Microbiome Therapeutic Drugs Sales Value, Gross Margin and Global Share (2019-2021)
Table Bristol-Myers Squibb Company Information
Table Bristol-Myers Squibb Product Introduction
Table Bristol-Myers Squibb Human Microbiome Therapeutic Drugs Sales Value, Gross Margin and Global Share (2019-2021)